Lina Zhao
Harbin, 150081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Treatment outcomes of zanubrutinib-based regimen in newly diagnosed patients with MYC/BCL2 double-expressor diffuse large B-cell lymphoma: a retrospective multicenter real-world study.
Journal: Annals of hematology
Published: May 07, 2025
Oncolytic virus oHSV2 combined with PD-1/PD-L1 inhibitors exert antitumor activity by mediating CD4 + T and CD8 + T cell infiltration in the lymphoma tumor microenvironment.
Journal: Autoimmunity
Published: September 22, 2023
LncRNA SNHG14/miR-5590-3p/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1/PD-L1 checkpoint.
Journal: Cell death & disease
Published: July 26, 2019
Significance of the microRNA‑17‑92 gene cluster expressed in B‑cell non‑Hodgkin's lymphoma.
Journal: Molecular medicine reports
Published: October 31, 2017
Nano-Hydroxyapatite-Derived Drug and Gene Co-Delivery System for Anti-Angiogenesis Therapy of Breast Cancer.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: October 03, 2017
BTLA marks a less cytotoxic T-cell subset in diffuse large B-cell lymphoma with high expression of checkpoints.
Journal: Experimental hematology
Published: September 30, 2017
The prognostic value of circulating tumor cells lacking cytokeratins in metastatic breast cancer patients.
Journal: Journal of cancer research and therapeutics
Published: April 12, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026